# Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)

> **NCT01527019** · PHASE3 · WITHDRAWN · sponsor: **Eurofarma Laboratorios S.A.**

## Conditions studied

- Cystitis

## Interventions

- **DRUG:** Norfloxacin
- **DRUG:** Cephalosporins
- **DRUG:** Cephalosporins

## Key facts

- **NCT ID:** NCT01527019
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-10
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** the company suspended the persecution of this combination
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527019, "Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT01527019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*